{"name":"FHI 360","slug":"fhi-360","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":11,"colorKey":"oncology","drugs":[{"name":"DMPA","genericName":"DMPA","slug":"dmpa","indication":"Other","status":"marketed"},{"name":"ETHINYL ESTRADIOL AND LEVOGESTREL","genericName":"ETHINYL ESTRADIOL AND LEVOGESTREL","slug":"ethinyl-estradiol-and-levogestrel","indication":"Contraception / prevention of pregnancy","status":"marketed"},{"name":"Implanon®","genericName":"Implanon®","slug":"implanon","indication":"Long-acting reversible contraception in women of reproductive age","status":"marketed"},{"name":"Jadelle","genericName":"Jadelle","slug":"jadelle","indication":"Other","status":"phase_1"},{"name":"LNG","genericName":"LNG","slug":"lng","indication":"Oral contraception","status":"marketed"},{"name":"Mirena®","genericName":"Mirena®","slug":"mirena","indication":"Other","status":"marketed"},{"name":"Mona Lisa® NT Cu380 Mini","genericName":"Mona Lisa® NT Cu380 Mini","slug":"mona-lisa-nt-cu380-mini","indication":"Contraception in women of reproductive age","status":"phase_3"},{"name":"Oral contraceptives--ethinyl estradiol, levonorgestrel","genericName":"Oral contraceptives--ethinyl estradiol, levonorgestrel","slug":"oral-contraceptives-ethinyl-estradiol-levonorgestrel","indication":"Other","status":"marketed"},{"name":"ParaGard®","genericName":"ParaGard®","slug":"paragard","indication":"Contraception in women of reproductive age","status":"marketed"},{"name":"ParaGard® TCu380A","genericName":"ParaGard® TCu380A","slug":"paragard-tcu380a","indication":"Contraception in women of reproductive age","status":"phase_3"},{"name":"Sayana Press","genericName":"Sayana Press","slug":"sayana-press","indication":"Other","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"oral contraceptives","genericName":"oral contraceptives","slug":"oral-contraceptives","indication":"Contraception / prevention of pregnancy","status":"marketed"}]}],"pipeline":[{"name":"DMPA","genericName":"DMPA","slug":"dmpa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ETHINYL ESTRADIOL AND LEVOGESTREL","genericName":"ETHINYL ESTRADIOL AND LEVOGESTREL","slug":"ethinyl-estradiol-and-levogestrel","phase":"marketed","mechanism":"This combination oral contraceptive prevents pregnancy by suppressing ovulation through hormonal inhibition of the hypothalamic-pituitary-ovarian axis.","indications":["Contraception / prevention of pregnancy"],"catalyst":""},{"name":"Implanon®","genericName":"Implanon®","slug":"implanon","phase":"marketed","mechanism":"Implanon® releases a steady dose of the progestin etonogestrel subdermally to prevent ovulation and thicken cervical mucus, providing long-acting reversible contraception.","indications":["Long-acting reversible contraception in women of reproductive age"],"catalyst":""},{"name":"Jadelle","genericName":"Jadelle","slug":"jadelle","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LNG","genericName":"LNG","slug":"lng","phase":"marketed","mechanism":"LNG (levonorgestrel) is a synthetic progestin that prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial conditions.","indications":["Oral contraception","Emergency contraception (Plan B)","Intrauterine contraceptive device"],"catalyst":""},{"name":"Mirena®","genericName":"Mirena®","slug":"mirena","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mona Lisa® NT Cu380 Mini","genericName":"Mona Lisa® NT Cu380 Mini","slug":"mona-lisa-nt-cu380-mini","phase":"phase_3","mechanism":"A copper-containing intrauterine device that prevents pregnancy by releasing copper ions that create a hostile environment for sperm and embryo implantation.","indications":["Contraception in women of reproductive age"],"catalyst":""},{"name":"Oral contraceptives--ethinyl estradiol, levonorgestrel","genericName":"Oral contraceptives--ethinyl estradiol, levonorgestrel","slug":"oral-contraceptives-ethinyl-estradiol-levonorgestrel","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ParaGard®","genericName":"ParaGard®","slug":"paragard","phase":"marketed","mechanism":"ParaGard is a copper-containing intrauterine device (IUD) that prevents pregnancy by creating a toxic environment for sperm and inhibiting fertilization and implantation.","indications":["Contraception in women of reproductive age"],"catalyst":""},{"name":"ParaGard® TCu380A","genericName":"ParaGard® TCu380A","slug":"paragard-tcu380a","phase":"phase_3","mechanism":"ParaGard TCu380A is a copper-releasing intrauterine device that prevents pregnancy through copper ion toxicity to sperm and alteration of the uterine environment.","indications":["Contraception in women of reproductive age"],"catalyst":""},{"name":"Sayana Press","genericName":"Sayana Press","slug":"sayana-press","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"oral contraceptives","genericName":"oral contraceptives","slug":"oral-contraceptives","phase":"marketed","mechanism":"Oral contraceptives prevent pregnancy by suppressing ovulation through hormonal inhibition of the hypothalamic-pituitary-gonadal axis.","indications":["Contraception / prevention of pregnancy","Menstrual cycle regulation","Treatment of acne","Endometriosis management","Polycystic ovary syndrome (PCOS) symptom management"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxObExQVktyT0VjN2ZCU0xBSjJ1a09qdTR2dzBESE9iaUJqelhlNHBaQWY3QnFNbjZlREZKalFhVWZXdEJfeE01eHZFbTV3ZldtR1NiMmtSM0tVUXdZWHpGY01oOFFiTmZwMUh1bjIzWFdlanNZMlBFT1NxamRnQXh4dE13?oc=5","date":"2025-09-29","type":"pipeline","source":"Devex","summary":"How FHI 360 has adapted to a year of chaos - Devex","headline":"How FHI 360 has adapted to a year of chaos","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQQWJWVHE3cHJiQS1jejdYS21MbmhzRS16T1JZQ3VTQldMRHkzd2hPT0RxVUxscUNaaHZPWEgwV0RUX3NFNklUa2pRUV9Bbi16N3BsVDZId2w4NVVEcWQ1SEt2NGJGNEFWWHlSdm1ZQ1RLc21pRHN6am12TUlselMySHV2NW1hMjRCWnJ6bnJDdUtuZGdoRVdUQTZCSlpBZw?oc=5","date":"2025-09-29","type":"pipeline","source":"Devex","summary":"Devex Newswire: 2 INGOs on cuts, coping, regrouping, and rebounding - Devex","headline":"Devex Newswire: 2 INGOs on cuts, coping, regrouping, and rebounding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE8yb0RYSVhlVkV4MTNoWFJPdHdFbzMwUlVLMnJfNnk0bDFBUGhyWEdWQ3p6ZXJ1cnJSYnhqUzdyYTFqdm9NWmdBdGl0bkY5QXdJTUR4aDFXQjkyeUxKVVQyb0tMV2tuS0k?oc=5","date":"2025-05-06","type":"pipeline","source":"FHI 360","summary":"Global health security - FHI 360","headline":"Global health security - FHI 360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPNkJWZGg1VS1CSG9qQjlxVjBZTFpkeDI3c2tyVnhVRGpzOHNIbGR1ekkxNDAzU1dKeFk0ZWkweEo5cjRic0FxTTQyM2lNYUthcUVrZTl6c0xKcWx0WjJleUlrSXplYzVDZjF1N21aTUFWU1l6S3NqN2hWRi0xNk52QlVYM0V6QXlHX0RyNGVkcnJpbkJPU2ZTRXdjSnBoeTdWY2trVEM0M2UxZHJS?oc=5","date":"2025-04-21","type":"earnings","source":"The Business Journals","summary":"After devastating Trump cuts, nonprofit CEO outlines path forward - The Business Journals","headline":"After devastating Trump cuts, nonprofit CEO outlines path forward","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE41ZVE4TjRFZlo5YVAyUUFRVEtqS1oxYkpxNWVTSWhOVFFGQzJPWEg1YnA4aG1meWs3SWlEM2ZNQ1RqODlJOW14Yk5ZWnh2WFNIVVNrY1FNNG44bkc0WjU2RTBEZFdINnJLTE9EMk50ZFh4cXFPQ3lVbEJ3?oc=5","date":"2025-04-15","type":"pipeline","source":"Strauss Borrelli PLLC","summary":"FHI 360 WARN Act Investigation - Strauss Borrelli PLLC","headline":"FHI 360 WARN Act Investigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5QV01WZ0NJdThLY2lyYnFIWXZTUTBzM0luN2dvd1RZM1doSUVuY2NtZktSdTVLLXRCSG8zY0xLaDBfSVdwdExISDdQWjZRaVNKS0VEMEVMb3g5dzdyTUJHVXJaQ1lqTTRCeHFuSXQwZw?oc=5","date":"2024-07-31","type":"deal","source":"FHI 360","summary":"Partnering with young people - FHI 360","headline":"Partnering with young people - FHI 360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNTkh4MTgzMlNCR2JFOU4xeEhZRWhLVjliV3hmdXFiVnYzdlR1dnpWeFRhb0V1M1k5dmg5X3NYY1EwYXhabVNQRHdSY014R2ZBUDZuLUlnRG5KVjlTZUNJZm9xWlRiRTJNQVZic2lTUkhhN3JrMXZlT1F1VFZOLWU5Uk1FaFU1dFo4Q0RuMGhUYWw?oc=5","date":"2024-03-20","type":"pipeline","source":"FHI 360","summary":"Ukraine Humanitarian Assistance Response Program (UHARP) - FHI 360","headline":"Ukraine Humanitarian Assistance Response Program (UHARP) - FHI 360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQSlBpMzRhSm90Y1NETk1NMTVkRkhuVVhEVzlmSVNpMkswOThyejNTNUJiWGItbU1MQnBDVVZRbnNNb3NQNEYySDdHM2RXd05tXzhNY1dqMmRHcDZnckdFT3hwR3BUS3N1RjNmSmhwN1BYaEtIMkZIazcxQmdxRnJnV2NmVWdOT29LWEpSa2JlMi1EcWJF?oc=5","date":"2024-03-20","type":"pipeline","source":"FHI 360","summary":"Integrated Response to Affected Mozambique Populations (IRAMP) - FHI 360","headline":"Integrated Response to Affected Mozambique Populations (IRAMP) - FHI 360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1UdmJNdjU4U181bGhQR2x5WHpyS2JVZ09NVmdvaUJneDU1X2oxc3Q5dl9VMjBrMFdseTZVQ3F3TW5tUlplZGFwbWtiS09VczBpRjh1RA?oc=5","date":"2024-03-17","type":"pipeline","source":"FHI 360","summary":"Thailand - FHI 360","headline":"Thailand - FHI 360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE45REliVmpuMkhIaUd6b0VxekYxc0lGeXJiRGFmdU9fTlAwNFVhUVFvMWczZGhiNDNMOVRGaFhpR2ViVXdYQTNGNTU1RFF0R2l4?oc=5","date":"2024-03-17","type":"pipeline","source":"FHI 360","summary":"Kenya - FHI 360","headline":"Kenya - FHI 360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxORnREX1FpWDdGMElRUG5LMy1KT19paU9JSXhVVkw0bG82OFB1bW8zTTBacllpQ0F5Y2laX1dFb2VvWHhUOXBRNUNaSk1RUDdfb19LVWNnWUlDelFpYkRSX2t3QzJ6RllFc1VMOFJXdEJRQlQ0Y3pBNFpwUjhVNDRRRWIyNWdndVJ5Yk5EckJsZ25qWVN1NXc?oc=5","date":"2024-03-17","type":"pipeline","source":"FHI 360","summary":"Scaling Up Integrated Humanitarian Assistance to Yemen (SUIHAY) II - FHI 360","headline":"Scaling Up Integrated Humanitarian Assistance to Yemen (SUIHAY) II - FHI 360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE04WUZXbURBQVJOZWFLMEIweGc0WVBSbDh0ajFqUVZnb21udFd1Vkh2MWNLamp0TF8tSlpxaE5obENWTzhWMjl2RFdWSFMwUUFkWlE?oc=5","date":"2024-03-17","type":"pipeline","source":"FHI 360","summary":"Uganda - FHI 360","headline":"Uganda - FHI 360","sentiment":"neutral"}],"patents":[],"drugCount":12,"phaseCounts":{"marketed":9,"phase_1":1,"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}